Position in LNSR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$281,228
+$5,876 QoQ
Shares Held
49,252
+6.6% QoQ
Ownership
0.401%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 74 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNSR Over Time
Shares Held
Position Value (USD)
Derivatives in LNSR
reported options exposure · as of Mar 31, 2026CallValue
$202,640
CallShares
34,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Centiva Capital, LP holds $17,999,021 across 26 Medical Devices names. LNSR ranks #12 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
150,288 | $6,414,291 | |
| 2 | PEN |
Penumbra Inc
|
15,000 | $4,736,250 | |
| 3 | 50,000 | $1,244,000 | |||
| 4 | EW |
Edwards Lifesciences Corp
|
9,122 | $825,176 | |
| 5 | BRKR |
Bruker Corp
|
12,000 | $722,160 | |
| 6 | INMD |
InMode Ltd.
|
26,950 | $394,009 | |
| 7 | STIM |
Neuronetics, Inc.
|
285,913 | $371,686 | |
| 8 | PRCT |
PROCEPT BioRobotics Corp
|
15,562 | $351,389 |
All Filings in LNSR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $281,228 | 49,252 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $275,352 | 46,200 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $202,640 | 34,000 | Call | Sole | 2026-05-14 | |
| 2025-12-31 | $510,557 | 43,900 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $553,378 | 47,582 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $587,637 | 47,582 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $542,165 | 43,900 | Call | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||